2021
DOI: 10.17061/phrp3142119
|View full text |Cite
|
Sign up to set email alerts
|

Funding for health policy and systems research in the Eastern Mediterranean region: amount, source and key determinants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 12 publications
0
7
0
Order By: Relevance
“…Although the path of promoting evidence-informed policies and practice is a long and winding road in the EMR [ 21 , 61 , 62 ], the COVID-19 pandemic has opened substantial windows of opportunity for accelerating action toward evidence-informed policymaking with emphasis on providing access to well-packaged, relevant, and updated synthesis of the best available evidence on priority topics in a timely manner [ 6 , 63 ]. Study findings can inform the work of researchers, governments, and funders seeking to promote evidence-informed health policymaking and practice in their own context.…”
Section: Discussionmentioning
confidence: 99%
“…Although the path of promoting evidence-informed policies and practice is a long and winding road in the EMR [ 21 , 61 , 62 ], the COVID-19 pandemic has opened substantial windows of opportunity for accelerating action toward evidence-informed policymaking with emphasis on providing access to well-packaged, relevant, and updated synthesis of the best available evidence on priority topics in a timely manner [ 6 , 63 ]. Study findings can inform the work of researchers, governments, and funders seeking to promote evidence-informed health policymaking and practice in their own context.…”
Section: Discussionmentioning
confidence: 99%
“…Most of the identified publications did not report a funding source, which could be due to limited funding opportunities or simply the likely dominance of cross-sectional studies and reviews, which are relatively less expensive, take less time to conduct, and require less infrastructure than, for example, clinical trials or prospective cohort studies [ 56 ]. The limited funding opportunities in the EMR may be related to the chronic underinvestment in research and development systems in the region, both financially and politically [ 57 ], exacerbated by the economic damage caused by the COVID-19 pandemic and the overreliance of some regional countries on external funding [ 58 ], although some major donors, such as the United Kingdom, have recently reduced their external funding [ 59 ]. Studies have also shown that research in the health care sector is not a top funding priority for governments, the private sector, or organizations in the EMR [ 57 ] and that R&D spending as a percentage of the gross domestic product (GDP) in the region is among the lowest in the world, despite significant differences in the GDP among member countries [ 58 , 60 , 61 ].…”
Section: Discussionmentioning
confidence: 99%
“…The limited funding opportunities in the EMR may be related to the chronic underinvestment in research and development systems in the region, both financially and politically [ 57 ], exacerbated by the economic damage caused by the COVID-19 pandemic and the overreliance of some regional countries on external funding [ 58 ], although some major donors, such as the United Kingdom, have recently reduced their external funding [ 59 ]. Studies have also shown that research in the health care sector is not a top funding priority for governments, the private sector, or organizations in the EMR [ 57 ] and that R&D spending as a percentage of the gross domestic product (GDP) in the region is among the lowest in the world, despite significant differences in the GDP among member countries [ 58 , 60 , 61 ]. In EMR countries, R&D spending as a percentage of the GDP ranged from as low as 0.02% in Syria and Sudan in 2015 and 2019, respectively, to 1.3% in the UAE in 2018 compared to the global average of 2.27% in 2018 [ 58 , 61 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The Eastern Mediterranean region includes 22 countries, with a total population of nearly 680 million that is diverse in terms of demographic, geographic, political, and socioeconomic characteristics. Research and development funding in the Eastern Mediterranean is among the lowest globally, and health research may not be considered as a priority for funding by governments in the region (El Rabbat et al, 2021). Given these challenges, D&I research can play an integral role in the region in improving health care delivery and in reducing health inequities by promoting the uptake of evidencebased practices adapted to diverse contexts.…”
Section: Introductionmentioning
confidence: 99%